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Background: Three decades since the first HIV-1 infected patients in Rwanda were identified in 1983; the Acquired
Immunodeficiency Syndrome epidemic has had a devastating history and is still a major public health challenge in
the country. This study was aimed at assessing socioeconomic, clinical and biological risk factors for mother – to –
child transmission of HIV- in Muhima health centre (Kigali/Rwanda).
Methods: The prospective cohort study was conducted at Muhima Health centre (Kigali/Rwanda).
During the study period (May 2007 – April 2010), of 8,669 pregnant women who attended antenatal visits and
screened for HIV-1, 736 tested HIV-1 positive and among them 700 were eligible study participants. Hemoglobin,
CD4 count and viral load tests were performed for participant mothers and HIV-1 testing using DNA PCR technique
for infants.
Follow up data for eligible mother-infant pairs were obtained from women themselves and log books in Muhima
health centre and maternity, using a structured questionnaire.
Predictors of mother-to-child transmission of HIV-1 were assessed by multivariable logistic regression analysis.
Results: Among the 679 exposed and followed-up infants, HIV-1 status was significantly associated with disclosure
of HIV status to partner both at 6 weeks of age (non-disclosure of HIV status, adjusted odds ratio [AOR] 4.68, CI 1.39
to 15.77, p < 0.05; compared to disclosure) and at 6 months of age (non-disclosure of HIV status, AOR, 3.41, CI 1.09
to 10.65, p < 0.05, compared to disclosure).
A significant association between mother’s viral load (HIV-1 RNA) and infant HIV-1 status was found both at 6 weeks
of age (> = 1000 copies/ml, AOR 7.30, CI 2.65 to 20.08, p < 0.01, compared to <1000 copies/ml) and at 6 months of
age (> = 1000 copies/ml, AOR 4.60, CI 1.84 to 11.49, p < 0.01, compared to <1000 copies/ml).
Conclusion: In this study, the most relevant factors independently associated with increased risk of mother – to –
child transmission of HIV-1 included non-disclosure of HIV status to partner and high HIV-1 RNA. Members of this
cohort also showed socioeconomic inequalities, with unmarried status carrying higher risk of undisclosed HIV status.
The monitoring of maternal HIV-1 RNA level might be considered as a routinely used test to assess the risk of
transmission with the goal of achieving viral suppression as critical for elimination of pediatric HIV, particularly in
breastfeeding populations.
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Three decades since the first HIV-1 infected patients
in Rwanda were identified (1983), the Acquired
Immunodeficiency Syndrome (AIDS) epidemic has
had a devastating history and is still a major public health
challenge in country [1,2].
At the end of 2010, an estimated 34 million people [31.6
million-35.2 million] were living with HIV worldwide, up
17% from 2001. The proportion of women among people
living with HIV has remained stable at 50% globally, but
they are more affected in Sub-Saharan Africa (59% of all
people living with HIV). Mother-to-child transmission of
HIV remains the primary mode of child contamination
during pregnancy, childbirth or breastfeeding. It is
estimated that every day there are over 1,000 new HIV
infections in children, with vast majority occurring in
Sub-Saharan Africa. Nearly 370,000 [230,000 - 510,000]
children were infected with HIV through mother- to-
child transmission globally in 2009. The scaling up of
effective interventions for the prevention of HIV transmis-
sion from mother- to- child (PMTCT) is still limited
because of inadequate access to antenatal and postnatal
services, particularly in developing countries [3].
With a population of 10.4 million (2010), of whom ma-
jority are female (52%), young (67% have less than 25 years)
and living in rural areas (83%), Rwanda faces enormous
challenges of political, social, economic, health develop-
ment, and particularly those relating to the consequences
of the 1994 genocide. Its gross domestic product is
estimated at USD 540 $/capita (2010), with a high level of
poverty (56.9% below the poverty line, 2005) [4]. HIV trend
from Rwanda Demographic and Health surveys data shows
that adult HIV prevalence has remained unchanged from
2005 to 2010. Estimated nationally at 3%, 4% in women
and 2% in men, it is 8.7% in urban areas and 2.8% in rural
areas (2010) [5].
The programme for prevention of mother-to-child trans-
mission of HIV-1 was put in place in 1999, with a goal of
reducing the incidence of new HIV infections among
children born to HIV positive mothers, with the use of anti-
retroviral medicines [6,7]. The package of PMTCT services
provided during the study period (2007–2010) included
antenatal care with testing and counseling; essential obstet-
ric and neonatal care; triple therapy and dual therapy ARV
respectively for HIV-positive mothers and infants; as well
as family planning [8]. Country’s commitments, towards
eliminating new HIV infections among children by 2015
and keeping their mothers alive, are in line with the global
plan launched by the UN Secretary General in 2011. The
following specific targets were defined at global level:
overall transmission rate < 5% at the population level (<2%
in the absence of breastfeeding or measured at 6 weeks)
and the reduction of new pediatric HIV infections by 90%
from the estimated baseline [9].In developed countries, the rate of HIV transmission
from the mother to the child has been significantly
reduced to 1%, through the use of antiretroviral triple
therapy for HIV-infected mother, caesarean delivery and
formula feeding for the child. In Rwanda, the mother-to-
child transmission of HIV-1 before the era of antiretroviral
medicines, has affected more than one in four children
(25.7%) born to HIV-1 positive mothers [2].
During the decade of 2000s, the use of antiretroviral
drugs allowed for significant advance in the reduction of
HIV mother-to-child transmission. However, feeding
practices for exposed children still represent a major
challenge for populations with breastfeeding as the only
feeding alternative for child survival. Nearly all Rwandan
children are breastfed through the first year of life, with
about 70% of them receiving complementary foods by
age of 6 to 9 months [5].
Several studies support the role of socioeconomic,
clinical and biological risk factors for HIV-1 transmission
[8-12]. Based on this background, we initiated this study
to assess the role of socioeconomic, clinical and biological
factors in mother-to-child transmission of HIV-1 at
Muhima health centre (Kigali/Rwanda), where this type of
study has never been conducted. The site of the study
includes Muhima health centre & hospital, located in the
district of Nyarugenge (Kigali), with a population of about
287,529 inhabitants (2010).
This study is specifically expected to allow for
better understanding of risk factors, likely to limit
the effectiveness of the national strategy for elimination of
mother-to-child transmission of HIV-1. The knowledge
generated from this study in Muhima will guide the
national evidence-based response towards a multisectoral
approach, with both more effective health interventions
and specific socioeconomic strategies to address the HIV
pandemic in Rwanda [1,9,13].
Methods
Study design and population
The prospective cohort study was conducted at Muhima
health centre (Kigali/Rwanda).
All pregnant women diagnosed with HIV-1 and attending
PMTCT service at Muhima health centre were invited to
participate in the study, between May 2007 and April 2010.
Eligible study participants were pregnant HIV-1 infected
women, consenting to the study, who had attended ante-
natal visits or delivered at Muhima maternity and had
benefited from PMTCT interventions in line with the
national guidelines (based on combination of Zidovudine/
Lamivudine/Nevirapine for mothers during pregnancy,
childbirth and postnatal period and Nevirapine/Zidovudine
for newborn). Additional inclusion criteria was for
participants to be registered as residents within the specific
catchment area of Muhima health centre and therefore
Bucagu et al. Archives of Public Health 2013, 71:4 Page 3 of 12
http://www.archpublichealth.com/content/71/1/4expected to attend the postnatal follow up as
required. All HIV negative pregnant women, those
whose consent to the study was not obtained and
those living outside the catchment area of Muhima
were excluded from the study.
We estimated the sample size based on anticipated
HIV-1 infection of 4% at 6 weeks and absolute precision
in% points of 1.5, with a confidence interval (CI) of 95%.
A sample size of 656 was the minimum number required
for the study. During the study period, of 8,669 pregnant
women who attended antenatal visits and screened for
HIV-1 in Muhima health centre, 736 tested HIV-1 positive
and among them 700 were eligible study participants [14].
At enrolment, eligible participants were interviewed
by three trained PMTCT providers (2 data collectors
supervised by 1 medical doctor) until the determined
sample size of 700 women was reached. Information
was collected from each mother – infant pair for a
period of 6 months after childbirth, including specific
socioeconomic characteristics, clinical and biological
features. For twins, one member randomly selected
from each twin pair was included in the study.
Data collection and management
Follow up data for eligible mother-infant pairs, about
pregnancy, childbirth and postnatal period were obtained
from women themselves and log books in Muhima health
centre and maternity, using a structured questionnaire,
translated into Kinyarwanda by the principal investigator.
Those data included medical records and laboratory tests
results. As viral load was not a requirement for the na-
tional PMTCT protocol, it was performed by the Rwanda
National Referral laboratory for study participants at the
request of the author, using COBAS TaqMan HIV-1 test
or Amplicor HIV-1 Monitor test v1.5 (both from Roche
Diagnostic Corporation, Indianapolis, IN). This is nucleic
acid amplification test for the quantification of Human
Immunodeficiency Virus Type 1 RNA in human plasma.
Required data were collected anonymously, using
participant’s unique identifier, nationally provided by the
National Centre for Treatment and Research on AIDS,
Malaria, Tuberculosis and other epidemics (Rwanda
TRAC plus/Rwanda Ministry of Health).
The study was designed to allow for periodic re-
questioning of study participants, at birth, 6 weeks
and 7 months postpartum, 1 month after cessation
of breastfeeding as per the national guidelines [1].
Twenty –one study participants were considered lost
to follow up as they have not shown up for regular visits
and the study team unable to find HIV-1 tests results for
their infants at 6 weeks and/or at 6 months (Dried Blood
Spot method using PCR technique). Baseline data on
known variables, namely age, marital status, maternal
education, residence, wealth index were found to besufficiently similar to those of participants (679) who
remained in the study [15,16].
The data were double entered for all 700 questionnaires,
by a team of 2 data entry clerks supervised by a lecturer
from the University of Rwanda/School of Public Health.
Data quality assessment was performed in two steps: A
review of all the records for participants with caesarean
section as mode of delivery (121 cases) was conducted: 90%
of self-reports were confirmed by relevant medical records.
Information on mode of delivery, in this study, was
provided by the participant and confirmed with the mater-
nal health card. The quality control was meant for checking
data consistency between the study questionnaires and
medical records from the health facility where childbirth
took place. For 12 participants in the study (i.e. 10%),
expected data were not found in the Muhima hospital
register. The missing medical records were later found in a
logbook that was kept in the Kigali University Hospital
(CHUK). The logbook was taken by the CHUK team, when
it went back to its premises after rehabilitation (2009) and
temporary relocation in Muhima hospital (the study site) in
2007–2008.
In addition, all viral load tests results for 679 study
participants were jointly verified by the principal investi-
gator and the laboratory manager, before the required
payment could be executed by Muhima hospital.
The main outcome was cumulative incidence of
mother – to – child transmission of HIV-1. It was
measured at 6 weeks and 6 months of life among live
born children [17,18].
Data analysis
Background data were summarized with descriptive
statistics. Univariate analyses of associations were per-
formed using the chi squared test, Fisher’s test as appro-
priate. Potential risk factors for mother – to – child
transmission of HIV-1 were considered as covariates,
including: socioeconomic characteristics that included
mother’s age in years (< =24 years/> 24 years); marital
status (married/unmarried); mother’s education (no educa-
tion/primary education; secondary school and more);
parity (primiparous/multiparous); wealth index re-
categorized in 5 quintiles (poorest/second/middle/
fourth/richest) (Demographic Health Survey wealth
index model); disclosed HIV status to partner (yes/
no); sex of infant (male, female), infant feeding
choices during the first 6 months of life (exclusive
breastfeeding/artificial feeding/mixed feeding) [19].
Clinical factors were: mode of delivery (vaginal/instru-
ment assisted/cesarean section); type of ARV treatment
(prophylactic/curative); duration of ARV treatment prior
to delivery (< 6 weeks/> = 6 weeks).
Biological factors included hemoglobin during
pregnancy (<11 g/dl/> = 11 g/dl); CD4 count (< 350 cells/
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copies/mL/> = 1.000 copies/mL).
Predictors of mother-to-child transmission of HIV-1
were assessed by multivariable logistic regression. All
variables with potential association with the main out-
come – HIV-1 transmission, were entered into the logis-
tic regression model. Hosmer and Lemeshow test was
applied to check for how well the model fit. Variables
were held in the model if they reached a significance
level of P < 0.05.
In addition, to demonstrate the potential mediation
effect of HIV disclosure variable through which a focal
independent variable (marital status) is able to influence
the dependent variable (infant HIV status), as shown in
Figure 1, the following steps were tested, as applied in
social psychological research: first the independent vari-
able affects the mediator in the first equation; second, the
independent variable affects the dependent variable in the
second equation; and third, the mediator affects the
dependent variable in the third equation.
A series of regression models was used to quantify the
relationships between marital status and HIV status
disclosure (a); marital status and infant HIV status (b),
HIV status disclosure and infant HIV status (c) [20-23].
Statistical analyses were performed with STATA 12.0
(Stata Corp, College Station, TX) and Statistical Package
for the Social Sciences (SPSS) version 17.
Ethical considerations
The study protocol was reviewed and approved by
the Rwanda national ethical committee and the
research commission of University Teaching Hospital
of Kigali, in February 2007, with annual evaluation of
the study progress. An informed consent has been
obtained, with a written and signed document, for










Figure 1 Path diagram for mediation effect of HIV status
disclosure. Mothers and infants meeting inclusion criteria in the
study. Muhima health centre cohort, Kigali/Rwanda, 2007-2010 [21].
The following steps were tested, as applied in social psychological
research: first the independent variable affects the mediator in the
first equation (a); second, the independent variable affects the
dependent variable in the second equation (b); and third, the
mediator affects the dependent variable in the third equation (c).Results
Baseline characteristics
Socioeconomic, clinical and biological characteristics of
mother-infant pairs enrolled in the study are shown in
Table 1. Nearly 1 in 3 mothers (29.7%) were young, with
a median age of 27 years (range: 17 – 45 years). Majority
of mothers had only primary or no education (74.7%)
and were married (82.7%). Two in five (40.3%) study
participants were classified by wealth index quintiles as
poorest and poor. Over one fifth (21.5%) of women
were primiparas, with median number of 2 births (range:
1–9 births). For 18.9% of women, male partner’s HIV
status was not disclosed. Only 2.9% of babies were born at
home; for 17.8% of pregnant women, babies were
delivered by cesarean section. Over half (50.7%) of
exposed infants were females. The vast majority (86.1%) of
mothers reported that their children received exclusive
breastfeeding. At enrollment, the median hemoglobin was
12.20 g/dl (range: 6.30 – 19 g/dl); with median CD4 count
of 429.50 cells/mm3 (range: 11 – 1718 cells/mm3) and me-
dian viral load of 40 copies/ml (range: 40 – 890,000
copies/ml); 63.3% of participant mothers had a viral
load of less than 40 copies/ml. Of 679 mothers,
majority (51.8%) reported they have received HIV
chemoprophylaxis regimen and 77.5% have taken
ARVs for at least 6 weeks prior to childbirth.
Infant HIV-1 infection
The study enrolled a cohort of 700 HIV-1 infected preg-
nant women and their newborn. Of these 21 study
participants were lost to follow up and 679 pregnant
women had live births of 674 single babies and 10 twins
(Figure 2). At 6 weeks, of the 679 live born babies and
followed up, a total of 23 infants tested HIV-1 positive.
Among these, at 6 months, 22 infants were confirmed
HIV-1 infected and 1 infant uninfected with HIV.
Among the 656 initially HIV-negative infants, 4 died be-
fore 6 months of age (with no confirmed diagnosis). Of
the 652 remaining infants, 3 were confirmed HIV-1
infected between 6 weeks and 6 months of age (11.5% of
all infected infants). The overall HIV-1 cumulative inci-
dence of mother – to – child transmission rate was 3.7%
at 6 weeks to 6 months of age and 3.2% was at zero to 6 -
weeks of age.
Risk factors for mother-to-child transmission of HIV-1
In univariate analysis, among the 679 HIV exposed live
infants, there is a statistically significant association
between HIV-1 status of infants and their mothers’ mari-
tal status; parity; hemoglobin level, duration of ARV
treatment, CD4 count and viral load, as well as HIV
status disclosure to partner and infant feeding choices.
Variables not associated with HIV-1 status of infants
included mother’s age, mother’s education, wealth, mode
Table 1 Background characteristics of mothers and
infants meeting inclusion criteria in the study
Variable Number (N = 679) Percentage



























Type of feeding during first
6 months of life
exclusive breastfeeding 585 86.1
artificial feeding 80 11.8
mixed feeding 14 2.1
Mode of delivery
vaginal/instrument assisted 558 82.2
cesarean section 121 17.8
Hemoglobin during pregnancy
<11 g/dl 180 26.5
> = 11 g/dl 499 73.5
Type of ARV treatment
prophylactic 352 51.8
curative 327 48.2
Duration of ARV treatment prior
to delivery
less than 6 weeks 153 22.5
6 weeks or more 526 77.5
Table 1 Background characteristics of mothers and
infants meeting inclusion criteria in the study (Continued)
CD4 count
<350 cells/mm3 263 38.7
> = 350 cells/mm3 416 61.3
Viral load
<1000 copies/ml 517 76.1
> = 1000 copies/ml 162 23.9
Muhima health centre cohort, Kigali/Rwanda, 2007 – 2010.
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(Table 2).
In a multivariable logistic regression analysis (Table 3),
the most relevant variables that remained significant in
the model included disclosure of HIV status to partner
and viral load (HIV-1 RNA).
Among exposed infants, HIV-1 status was significantly
associated with disclosure of HIV status to partner both at
6 weeks of age (non-disclosure of HIV status, adjusted
odds ratio [AOR] 4.68, CI 1.39 to 15.77, p < 0.05; compared
to disclosure) and at 6 months of age (non-disclosure of
HIV status, AOR, 3.41, CI 1.09 to 10.65, p < 0.05, compared
to disclosure).
A significant association between mother’s viral load
(HIV-1 RNA) and infant HIV-1 status was found both at
6 weeks of age (> = 1000 copies/ml, AOR 7.30, CI 2.65
to 20.08, p < 0.01, compared to <1000 copies/ml) and at
6 months of age (> = 1000 copies/ml, AOR 4.60, CI 1.84
to 11.49, p < 0.01, compared to <1000 copies/ml).
In the study multivariable model, the following
covariates were found with limited statistical signifi-
cance: infant feeding choice at 6 months of age
(mixed feeding, AOR 9.64, CI 0.96 to 96.62, p < 0.1,
compared to exclusive breastfeeding); mother’s CD4
count both at 6 weeks of infant age (<350 cells/mm3,
AOR 4.83, CI 0.98 to 23.90, p < 0.1, compared to > =350
cells/mm3) and at 6 months of infant age (<350 cells/mm3,
AOR 3.82, CI 0.92 to 15.94, p < 0.1, compared to > =350
cells/mm3); mother’s hemoglobin level at 6 weeks of infant
age (<11 g/dl, AOR 2.58, CI 0.90 to 7.40, p < 0.1, compared
to > =11 g/dl).Discussion
This study assessed socioeconomic, clinical and biological
risk factors for mother – to – child transmission of HIV-1
among 679 infants (at 6 weeks) and 675 (at 6 months)
born to HIV infected mothers and followed up at Muhima
health centre (Kigali/Rwanda).
This vertical transmission occurs at three stages including
prepartum, intrapartum and postpartum (breastfeeding)
[24-26].
736 HIV-1 infected pregnant women were identified
700 eligible HIV-1 infected pregnant women
679 women included in the study
21 lost to follow up
23 HIV-1 positive 
infants at 6 weeks of 
life
656 HIV-1 negative 
infants at 6 weeks of 
life.
23 infants alive at 6 
months of life.
652 infants alive at 6 
months of life
684 live births including 10 
twins



















Figure 2 Muhima health centre cohort profile: mothers and infants meeting inclusion criteria in the study. Kigali/Rwanda, 2007-2010.
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mother – to – child transmission, HIV-1 exposed
infants whose mothers presented with no documented
mutual disclosure of HIV status and a higher HIV-1
RNA level.
Mutual disclosure of HIV status
Consistent with other studies, non-disclosure of HIV sta-
tus to partner emerged as an important factor for HIV-1
mother – to – child transmission in this cohort study.
Existing studies have increasingly shown disclosure as
a way to encourage prevention and non-disclosure
significantly associated with sexual risk behaviours.
Disclosure is of importance in PMTCT programmes
as it allows an individual to get spousal or family
support for preventive actions they may decide to
undertake, including approaches for adequate ARV
adherence [27-31].
Fear of stigma and rejection is thought to discourage
disclosure [32].Women appear to disclose, and to receive disclosure,
more frequently than do men. Partner disclosure is also
generally lower with casual partners than it is with
steady partners.
A positive correlation between disclosure and
social support has been documented in various
contexts. Socioeconomic factors (education) and
access to resources play an important role in influ-
encing disclosure, with lower rates of disclosure
associated with low-wage employment and economic
vulnerability [33].
In Zimbabwe, receiving HIV education during ante-
natal visits at least twice and referral for psychosocial
support were significantly protective [34] In Rwanda, a
package of strategies – including couple counseling and
community campaigns – seems to have overcome some
barriers to disclosure [32].
From the social psychological analysis applied in
this study, the required four conditions allowing for
testing the validity of the mediation model were
Table 2 Univariate analysis of factors associated with mother-to-child transmission of HIV-1 at 6 weeks and at
6 months of life
Variables Infant HIV-1 status at 6 weeks Infant HIV-1 status at 6 months
n HIV-(%) HIV + (%) P-value N HIV-(%) HIV + (%) P-value
Mother’s age, years
<=24 202 95.5 4.5 0.317 202 94.6 5.4 0.117
>24 477 97.1 2.9 473 97.0 3.0
Marital status
married 562 97.7 2.3 0.001 559 97.5 2.5 0.000
unmarried 117 91.5 8.5 116 90.5 9.5
Education
none/primary 509 96.5 3.5 0.710 508 96.3 3.7 0.930
secondary/university 170 97.1 2.9 167 96.4 3.6
Wealth
poorest 175 94.3 5.7 0.328 174 94.3 5.7 0.459
second 99 98.0 2.0 99 98.0 2.0
middle 143 97.2 2.8 143 97.2 2.8
fourth 145 96.6 3.4 144 95.8 4.2
richest 117 98.3 1.7 115 97.4 2.6
Parity
primipara 146 93.2 6.8 0.009 144 91.7 8.3 0.001
multiparous 533 97.6 2.4 531 97.6 2.4
Disclosed HIV status to partner
Yes 551 98.2 1.8 0.000 550 97.8 2.2 0.000
No 128 89.8 10.2 125 89.6 10.4
Place of delivery
home 20 90.0 10.0 0.097 20 90.0 10.0 0.130
facility 659 96.8 3.2 655 96.5 3.5
Sex of the infant
male 335 96.7 3.3 0.883 332 96.4 3.6 0.904
female 344 96.5 3.5 343 96.2 3.8
Type of feeding during first 6 months of life
exclusive breastfeeding 585 96.8 3.2 0.070 581 96.6 3.4 0.002
artificial feeding 80 97.5 2.5 80 97.5 2.5
mixt feeding 14 85.7 14.3 14 78.6 21.4
Mode of delivery
vaginal/instrument assisted 558 96.4 3.6 0.542 554 96.0 4.0 0.431
cesarean section 121 97.5 2.5 121 97.5 2.5
Hemoglobin during pregnancy
<11 g/dl 180 93.3 6.7 0.005 179 93.9 6.1 0.044
> = 11 g/dl 499 97.8 2.2 496 97.2 2.8
Type of ARV treatment
prophylactic 352 97.4 2.6 0.215 350 96.9 3.1 0.423
curative 327 95.7 4.3 325 95.7 4.3
Duration of ARV treatment prior to delivery
less than 6 weeks 153 93.5 6.5 0.014 152 94.1 5.9 0.100
6 weeks or more 526 97.5 2.5 523 96.9 3.1
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Table 2 Univariate analysis of factors associated with mother-to-child transmission of HIV-1 at 6 weeks and at
6 months of life (Continued)
CD4 count
<350 cells/mm3 263 94.3 5.7 0.009 261 94.3 5.7 0.028
> = 350 cells/mm3 416 98.1 1.9 414 97.6 2.4
Viral load
<1000 copies/ml 517 98.6 1.4 0.000 514 98.1 1.9 0.000
> = 1000 copies/ml 162 90.1 9.9 161 90.7 9.3
Muhima health centre cohort, Kigali/Rwanda, 2007 – 2010.
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perfect mediation model as the independent variable
(marital status) has shown no effect on the dependent
variable (infant HIV-1 status) when the mediator is
controlled (HIV status disclosure). Unmarried women
infected with HIV-1 have higher risk of HIV-1
mother-to-child transmission with undisclosed HIV
status, as a mediator. The mediator variable explains
how external physical events (independent variable)
take on internal psychological significance [21-23].Viral load
The level of HIV-1 RNA in maternal plasma remains
the major biological predictor of both early and late
mother-to-child transmission of the virus. HIV-
infected individuals who maintain increased levels of
HIV-1 RNA load, extended high viremics, can transmit
virus at higher rates. Combinatorial ART decreases HIV
replication, thus reducing rates of virus transmission
[35,36].
In addition, existing studies have shown that, for women
receiving HAART for prevention of HIV-1 transmission,
breast milk HIV-1 RNA level is associated with systemic
viral burden [37].
The total viral suppression (below 40 copies/mL for
this study) provides the most protective effect against
mother-to-child transmission of HIV-1 [38,39].
Achieving viral suppression by delivery to prevent
MTCT depends on maternal viral load baseline level
and time of HAART initiation during pregnancy as
shown by a UK study findings. This suggest that
with a viral load of more than 10,000 copies/mL and
especially with a viral load more than 100,000
copies/mL, the probability of achieving either less
than 50 copies/mL by the time of delivery is
compromised by delaying initiation of short-term
highly active antiretroviral therapy beyond 20.4 weeks
gestation [40].Breastfeeding
Like many studies investigating feeding choices for HIV-1
exposed infants in breastfeeding populations, the Muhima
cohort study results show that exclusive breastfeeding was
associated with a lower risk of postnatal transmission
at 6 months, compared with mixed feeding, but it
does not eliminate risk. The only method known to
completely eliminate breastfeeding associated HIV
transmission is not to breastfeed. This is recommended in
settings in which infant replacement feeding is affordable
and sustainable [41-44].
A prospective study in Zimbabwe with 14,110 mother-
newborn pairs followed for 2 years showed that early
mixed feeding, when compared with early breastfeeding,
was associated with a 2.5 fold (95CI 1.3 to 4.8) greater
risk of HIV infection or death at 18 months [45].
Breast milk protective mechanisms include factors
that have the ability to inactivate HIV and/or binding
to the infant mucosa and/or target cells. Milk also
contains many anti-inflammatory factors that would
limit viral replication within milk, as well as maintain
the integrity of both the mammary (reducing trans-
missibility) and the infant mucosal epithelia (reducing
susceptibility) [46].
The WHO infant feeding guidelines in the context
of HIV have been revised to ensure balance between
HIV prevention with protection from other causes of
child mortality. They recommend that national or
subnational authorities should decide whether health
services will principally counsel and support HIV
infected mothers to either avoid all breastfeeding or to
breastfeed and receive infant or maternal antiretroviral
prophylaxis [43].
In Rwandan general population, exclusive breast-
feeding is the norm. As reported by Rwanda Demo-
graphic and Health Survey 2010 results, eighty-five
percent of children under age of 6 months are exclu-
sively breastfed, 2 percent are given milk and plain
water, 7 percent get breast milk and non-milk
Table 3 Multivariable logistic regression analysis of risk
factors associated with mother-to-child transmission of











<=24 1.22 [0.41 - 3.64] 1.43 [0.53 - 3.89]
>24 1 1
Marital status
not currently married 1.42 [0.42 - 4.79] 1.55 [0.49 - 4.90]
currently married 1 1
Education attainment
none/primary 1.09 [0.29 - 4.08] 1.09 [0.33 - 3.63]
secondary/university education 1 1
Wealth index
poorest 2.07 [0.31 - 14.01] 1.37 [0.27 - 7.01]
second 0.77 [0.07 - 8.16] 0.39 [0.05 - 3.44]
middle 0.82 [0.11 - 5.90] 0.53 [0.09 - 2.94]
fourth 1.33 [0.21 - 8.32] 1.05 [0.23 - 4.91]
richest 1 1
Parity
primiparous 1.97 [0.65 - 5.94] 2.33 [0.84 - 6.41]
multiparous 1 1





health facility 1 1
child’s sex
Male 1.27[0.49-3.34] 1.21 [0.49 - 2.98]
Female 1 1
Type of feeding for the child
during first 6 months of life
mixed feeding 5.5[0.40-74.82] 9.64*[0.96-96.62]
artificial feeding 2.45[0.39-15.24] 1.99[0.36-11.10]
exclusive breastfeeding 1 1
Mode of delivery
vaginal/instrument assisted 0.66[0.17-2.57] 0.91 [0.24 - 3.40]
cesarean section 1 1
Hemoglobin
<11 g/dl 2.58*[0.90-7.40] 1.73 [0.65 - 4.62]
> = 11 g/dl 1 1
Type of ARV treatment received
prophylactic 1.82[0.38-8.73] 1.79 [0.43 - 7.41]
curative 1 1
Table 3 Multivariable logistic regression analysis of risk
factors associated with mother-to-child transmission of
HIV at 6 weeks and at 6 months of life (Continued)
duration of ARV prophylaxis/
treatment
less than 6 weeks 2.24[0.81-6.16] 1.35 [0.51 - 3.57]
6 weeks or more 1 1
CD4 count
<350 cellules/mm3 4.83*[0.98-23.90] 3.82*[0.92-15.94]
> = 350 cellules/mm3 1 1
Viral load
>=1000 copies/ml 7.30***[2.65-20.08] 4.60***[1.84-11.49]
<1000 copies/ml 1 1
Observations 679 675
*** p < 0.01, ** p < 0.05, * p < 0.1.
The following variables were considered for inclusion in the logistic regression
model: mother’s age; marital status; wealth; parity; HIV status disclosure to
partner; place of delivery; mode of delivery; child sex; infant feeding choice;
hemoglobin; type of ARV treatment received; duration of ARV prophylaxis/
treatment; CD4 count and viral load (HIV-1 RNA).
Muhima health centre cohort, Kigali/Rwanda, 2007 – 2010.
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addition to breast milk [6]. With regard to mixed
feeding in the context of HIV/AIDS in Rwanda, an
evaluation of infant feeding and young child feeding
practices reported high prevalence of exclusive
breastfeeding with weaning at 4–6 months. The
author found no indication that mothers who mixed
fed did so because they believed their breast milk
was insufficient. This finding suggest that it should
be possible to achieve even higher rates of exclusive
breastfeeding if mothers are educated about the need
to avoid feeds other than breast milk and, if they are
supported, to have faith that their milk is adequate
for their babies, even if their health and nutritional
status are less than ideal [44].
CD4 count
Maternal CD4+ count has been used as an indicator
to assess eligibility for antiretroviral treatment &
prophylaxis for prevention of HIV-1 mother-to-child
transmission and low CD4+ lymphocyte count was
found associated with increased mother-to-child
transmission risk [47-53]. Available studies have also
shown that CD4 count increases with the use of
triple-drug combination therapy [54].
Hemoglobin
Studies conducted in Sub-Saharan Africa that have
found low maternal hemoglobin level (<11 g/dl)
during pregnancy, as a risk factor for HIV-1 mother-
to-child transmission [55-57]. Anemia is a common
clinical finding in HIV-infected patients. In these
Bucagu et al. Archives of Public Health 2013, 71:4 Page 10 of 12
http://www.archpublichealth.com/content/71/1/4patients, many factors may contribute to the develop-
ment of anemia, including nutritional deficiencies,
opportunistic infections, AIDS-related malignancies,
drug treatment and a direct effect of HIV on the
bone marrow. Iron maldistribution may increase suscepti-
bility to opportunistic infections and accelerate disease
progression [57].
This study has some limitations. The self-reporting
as an approach to provide survey data is likely to
introduce specific biases for factors such as infant
feeding practices, mutual disclosure of HIV status and
individual socioeconomic characteristics. Although
Muhima study findings corroborate those from
existing literature about major risk factors for
mother-to-child transmission of HIV-1 in breastfeeding
populations, it was only conducted in one of the 30
Rwanda districts and located in urban area. For the results
to be generalizable to the entire country there would be
need for larger studies.
Conclusion
In 679 mother – infant pairs followed at Muhima
health Centre (Rwanda), the most relevant factors
independently associated with increased risk of
mother – to – child transmission of HIV-1 included
non-disclosure of HIV status to partner and high
HIV-1 RNA. Members of this cohort also showed
socioeconomic inequalities, with unmarried status
carrying higher risk of undisclosed HIV status that,
as a mediator, was associated with higher risk of
MTCT. Such findings suggest that HIV status
disclosure to partner & HIV-1 RNA level are key
entry points for reducing HIV-1 mother-to-child
transmission in Rwanda. And more specifically, the
monitoring of HIV-1 RNA level might be considered
as a routinely used test to assess the risk of trans-
mission with the goal of achieving viral suppression
as critical for elimination of transmission, particu-
larly in breastfeeding populations. In addition,
further research is needed to identify most effective
interventions to get optimal mutual disclosure of
HIV status for Rwanda PMTCT services & clients.
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